Patient Access to drug treatment therapies; and drug cost and drug pricing reform. Oversight of the pharmaceutical industry and drug pricing. Policies as they relate to PBMs Issues related to the FY2026 budget and appropriations process
2025 · 4th Quarter (Oct 1 - Dec 31)
ABBVIE, INC.
Filed by FEDERAL STREET STRATEGIES, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Jan 21, 2026
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- FEDERAL STREET STRATEGIES, LLC
- Client
- ABBVIE, INC.
- Filing UUID
- 44ffd779-1ae0-4f87-b290-7877e7f2c6c4
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Medicare Part D policies. Monitoring Policies related to the 340b program. Issues related to the implementation of the Inflation Reduction Act Issues related to the FY2026 budget and appropriations process
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.